A comprehensive database of all TGA listed medical cannabis products in Australia. The first clinician-only platform enhancing clarity in cannabis, confidence in care.

Client login

The Importance of Comprehensive Medicinal Cannabis Databases for Medicinal Cannabis Doctors

In Australia, the use of medicinal cannabis has grown rapidly since its legalisation for medical purposes in 2016. With more than 320,000 Special Access Scheme (SAS) approvals granted by late 2022 and over 800 cannabis products available, general practitioners and authorised prescribers face a complex and evolving landscape. A comprehensive medicinal cannabis database plays a crucial role in supporting evidence-based prescribing, maintaining TGA compliance, and improving patient outcomes.

Why General Practitioners Need More Medicinal Cannabis Knowledge 

Australian general practitioners are often the first point of contact for patients seeking medicinal cannabis for chronic conditions such as pain, anxiety, or sleep disorders. However, many clinicians report limited knowledge about medicinal cannabis and its therapeutic applications. In a 2020 study, nearly 67% of surveyed GPs felt their knowledge was inadequate, while only 22% had prescribed cannabis.

This highlights the need for centralised, accurate information on cannabis as medicine. Unlike conventional drugs, medicinal cannabis products differ greatly in cannabinoid content, form (oil, capsule, dried flower), and clinical indications. Prescribers must navigate both clinical uncertainty and regulatory requirements.

What is a Medicinal Cannabis Database?

A medicinal cannabis database or knowledge base is an organised collection of medicinal cannabis products with detailed information, tailored for practitioners. Practitioners can use the medicinal cannabis database to find and learn about different medicinal cannabis products, to help when issuing prescriptions for their patients. 

Why Comprehensive Databases Matter

A dedicated medicinal cannabis database offers multiple benefits for authorised prescribers:

1. Product Clarity

Databases provide up-to-date listings of all TGA-notified medicinal cannabis products. This helps doctors compare options by THC/CBD content, form, category, and more. Since most products are unregistered and require SAS or Authorised Prescriber (AP) approval, knowing the correct category (e.g., Category 1 for CBD-only) is essential for compliance.

2. Evidence-Based Guidance

Databases link to clinical guidelines and systematic reviews on cannabis for medical conditions. This enables prescribers to evaluate the medical literature and assess the benefits of medicinal cannabis for conditions like epilepsy, chronic pain, and nausea. Such resources help address the gap in formal training and support safe prescribing practices.

3. Simplified Regulatory Navigation

Prescribing under the SAS or AP scheme involves documentation and understanding of TGA rules. A cannabis database can offer templates, checklists, and alerts about regulatory updates. This ensures prescribers stay compliant and avoid delays or errors.

4. Safety and Dosing Information

Knowing how to titrate doses and anticipate side effects (e.g., sedation or cognitive impairment from THC) is vital. A database can summarise this data, improving patient safety and guiding doctors in tailoring medicinal cannabis use to each patient’s needs.

5. Improved Patient Access

Doctors with access to reliable data can confidently choose suitable products and access pathways. This shortens the time from consultation to prescription fulfilment, improving patient access and treatment outcomes.

Addressing Prescriber Concerns

Despite growing interest in prescribing medicinal cannabis, many practitioners remain cautious. Concerns include a lack of standardised dosing, potential side effects, and insufficient evidence for some indications. A well-structured database helps bridge this knowledge gap.

By centralising clinical guidance and public health updates, the database empowers practitioners to make informed decisions and counsel patients effectively. It distinguishes between medical use and recreational cannabis use, reinforcing the therapeutic intent of prescribed cannabis.

Enhancing Clinical Outcomes

Comprehensive databases improve:

These factors contribute to improved patient satisfaction and clinical outcomes. As more doctors feel supported in their practice, access to medicinal cannabis expands in a responsible and regulated manner.

The Path Forward

With attitudes of Australian general practitioners towards medicinal cannabis becoming more positive, the demand for reliable resources is rising. A comprehensive database provides a vital foundation for safe, informed prescribing. It supports doctors in:

By integrating data, guidelines, and access tools, such a database transforms cannabis prescribing from a niche challenge into a standardised medical process. It enhances prescriber knowledge, patient safety, and public trust in the use of cannabis for medical treatment.

Conclusion

Medicinal cannabis prescribing in Australia is no longer a fringe activity. With demand increasing and the benefits of medicinal cannabis becoming clearer, doctors need dependable resources. A comprehensive database streamlines prescribing, strengthens clinical decision-making, and ensures compliance with TGA standards. For medical practitioners, it’s an essential tool in delivering effective, personalised care in the era of cannabis medicine.

medicinal cannabis

The Compendium provides authorised prescribers with a dedicated, clinician-focused database that bridges the gap between clinical practice and regulatory demands. Whether you’re navigating the Special Access Scheme or seeking evidence-based insights for patient treatment plans, The Compendium offers the clarity, compliance, and confidence required for modern cannabis prescribing.

Start prescribing with confidence. Explore The Compendium today and empower your cannabis clinical practice.

Leave a Reply

Register your interest in The Compendium

“*” indicates required fields

PRIVACY COLLECTION NOTICE​

This Privacy Collection Notice describes how PHENIX HEALTH PTY LTD (ABN 22 607 822 266)  (we, us or our) collects and handles your personal information when you make an enquiry with us. We collect personal information from you so that we can respond to your enquiry and for related purposes set out in our Privacy Policy, available on our website (or on request).

We may disclose this personal information to third parties, including our personnel, related entities, any third parties engaged by us and acting on our behalf and as otherwise set out in our Privacy Policy.

We store personal information in Australia. Where we disclose your personal information to third parties, those third parties may store, transfer or access personal information outside of Australia.

If you do not provide your personal information to us, it may affect our ability to do business with you.

Please see our Privacy Policy for more information about how we collect, store, use and disclose your personal information, including details about overseas disclosure, access, correction, how you can make a privacy-related complaint and our complaint-handling process.

If you have questions about our privacy practices, please contact us by email at: info@thecompendium.health. By providing your personal information to us, you agree to the collection, use, storage and disclosure of that information as described in this privacy collection notice.